Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
140.50    3.25 (2.36%)
Bid:
138.00
Ask:
144.50
Spread: 6.50 (4.71%)
Market Cap: £110.25m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Systems integration partner

13 May 2005 07:01

Xaar PLC13 May 2005 FOR IMMEDIATE RELEASE 13 May 2005 Xaar plc IMPIKA APPOINTED AS SYSTEMS INTEGRATION PARTNER Xaar plc ("Xaar"), the inkjet printing technology group headquartered inCambridge, and IMPIKA SA ("IMPIKA") of Aubagne, France are pleased to announce ajoint agreement for the provision of integration services for Xaar printheadsand other products. Under the agreement both parties will co-operate to provide complete turnkeysolutions for clients wishing to use Xaar technology for their productionprocesses, to open up new applications and create bespoke solutions. IMPIKA haslong experience with inkjet, including its application to the printing ofplastic and smart cards, packaging, labelling as well as special applicationsfor printing on CDs, glass and metal. Impika is also developing solutions basedon its material jetting technology for microelectronics and biomedicalapplications. Nigel Berry, Deputy CEO of Xaar commented: "I am very pleased to announce thisrelationship with IMPIKA. We previously stated our intention to partner with asmall number of high quality integrators which can offer existing and potentialusers of our technology a complete package of integration skills and bespokeequipment. We have known the team at IMPIKA for some time now and have beenimpressed by their standards and innovation. I look forward to working withthem on future projects." Paul Morgavi, IMPIKA'S CEO said: "Xaar is a great partner for us and we arealready forming strong links with their technical and marketing teams. There isa clear synergy between Xaar and Impika with both parties introducing newmarkets into the joint relationship. Last year we introduced our C9000 productbased on Xaar's Leopard printhead and we are working on various projects foradapting our IPS print engine to the next generation of Xaar printheads, likethe Omnidot and HSS. Full commercial release of these products is anticipatedlater this year or early next year." About Xaar Xaar plc is a market-leading inkjet technology company. It targets the world'sindustrial, commercial and office printing markets. The industrial andcommercial printing markets are targeted by Xaar's own range of inkjet productsin conjunction with partners and other key players in those markets; the officeprinting market is approached through Xaar's strong list of licensees.Additional information about Xaar is available at www.xaar.co.uk. About IMPIKA: Created in March 2003 as a spin-out from Gemplus, IMPIKA is headquartered atAubagne in the south of France. IMPIKA offers high-performance industrialprinting and material jetting solutions using inkjet technology; it currentlyhas 37 employees. IMPIKA designs, develops, implements and markets hardware and softwaresolutions, as well as the required engineering as regards ink and materialjetting, for industrial applications including digital printing,microelectronics and biotechnologies. Additional information about IMPIKA isavailable at www.impika.com. Contacts Xaar plc: 01223-423663Ian Dinwoodie, Chief Executive www.xaar.co.ukNigel Berry, Group Finance Director & Deputy Chief Executive IMPIKA: +33 (0)4 42 62 43 00Paul Morgavi, CEO www.impika.com Bankside Consultants:Steve Liebmann 020-7444-4163 /07802-888159 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st May 20192:21 pmRNSTotal Voting Rights
1st May 201910:15 amRNSGrant of Options
30th Apr 20192:59 pmRNSHolding(s) in Company
2nd Apr 201910:31 amRNSTotal Voting Rights
21st Mar 20197:00 amRNSXaar plc 2018 Full Year Results
11th Mar 20197:00 amRNSTrading Update
1st Mar 20199:53 amRNSTotal Voting Rights
1st Feb 20191:12 pmRNSTotal Voting Rights
2nd Jan 20194:48 pmRNSBlock Listing Six Monthly Return
2nd Jan 20194:45 pmRNSTotal Voting Rights
2nd Jan 201912:07 pmRNSSecond Price Monitoring Extn
2nd Jan 201912:02 pmRNSPrice Monitoring Extension
28th Dec 20187:00 amRNSTrading Update
3rd Dec 20184:12 pmRNSTotal Voting Rights
20th Nov 20187:00 amRNSNEOS AND KELENN TECHNOLOGY ADOPT XAAR 5601
5th Nov 201811:12 amRNSHolding(s) in Company
1st Nov 20183:21 pmRNSTotal Voting Rights
24th Oct 20187:00 amRNSAppointment of CFO and Company Secretary
11th Oct 201812:07 pmRNSSecond Price Monitoring Extn
11th Oct 201812:02 pmRNSPrice Monitoring Extension
10th Oct 201812:07 pmRNSSecond Price Monitoring Extn
10th Oct 201812:02 pmRNSPrice Monitoring Extension
1st Oct 20185:20 pmRNSTotal Voting Rights
5th Sep 20187:00 amRNSW&H Chooses Xaar 5601
5th Sep 20187:00 amRNSXaar 2018 Interim Results
4th Sep 20188:30 amRNSTotal Voting Rights
4th Sep 20188:05 amRNSHolding(s) in Company
30th Aug 20187:00 amRNSTrading Update
1st Aug 20182:40 pmRNSTotal Voting Rights
12th Jul 20187:00 amRNSAnnouncement of 3D Printing Joint Investment
2nd Jul 20185:39 pmRNSBlock listing Interim Review
2nd Jul 20185:37 pmRNSTotal Voting Rights
27th Jun 20187:00 amRNSTrading Statement
1st Jun 20182:25 pmRNSTotal Voting Rights
30th May 20187:00 amRNSBoard Change
22nd May 201812:12 pmRNSResult of AGM
1st May 20185:02 pmRNSTotal Voting Rights
11th Apr 201812:02 pmRNSPrice Monitoring Extension
5th Apr 20189:38 amRNSGrant of Options
3rd Apr 201812:26 pmRNSTotal Voting Rights
3rd Apr 201810:54 amRNSBoard Change
23rd Mar 20182:10 pmRNSHolding(s) in Company
21st Mar 20187:00 amRNSXaar plc 2017 Full Year Results
20th Mar 20181:25 pmRNSHolding(s) in Company
12th Mar 201810:58 amRNSHolding(s) in Company
1st Mar 20183:57 pmRNSTotal Voting Rights
2nd Feb 20188:00 amRNSNotice of Scheduled Results
1st Feb 201811:11 amRNSTotal Voting Rights
5th Jan 20187:00 amRNSBlock listing Interim Review
5th Jan 20187:00 amRNSIssue of Equity - Share Scheme and Block Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.